Aurinia Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUPH and other ETFs, options, and stocks.

About AUPH

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

CEO

Peter S. Greenleaf

CEOPeter S. Greenleaf

Employees

130

Employees130

Headquarters

Edmonton, Alberta

HeadquartersEdmonton, Alberta

Founded

1993

Founded1993

Employees

130

Employees130

AUPH Key Statistics

Market cap

1.50B

Market cap1.50B

Price-Earnings ratio

27.15

Price-Earnings ratio27.15

Dividend yield

—

Dividend yield—

Average volume

3.47M

Average volume3.47M

High today

$11.67

High today$11.67

Low today

$11.32

Low today$11.32

Open price

$11.49

Open price$11.49

Volume

3.33M

Volume3.33M

52 Week high

$11.80

52 Week high$11.80

52 Week low

$5.29

52 Week low$5.29

Analyst ratings

86%

of 7 ratings

Buy

85.7%

Hold

14.3%

Sell

People also own

Based on the portfolios of people who own AUPH. This list is generated using Robinhood data, and it’s not a recommendation.